| Topic
|
Calculators
|
Purpose
|
| Coronary artery disease
|
ACTION ICU Score for Intensive Care in NSTEMI
|
Predicts risk of NSTEMI complications requiring ICU care
|
| MACE
|
ADAPT Protocol for Cardiac Event Risk
|
Assesses chest pain patients at 2 hours for risk of cardiac event
|
| DVT
|
AMUSE score
|
Evaluates the need to proceed with ultrasonography among patients with suspected DVT
|
| Anticoagulation
|
ATRIA Bleeding Risk Score
|
Determines bleeding risk for patients on warfarin
|
| Arrythmia
|
ATRIA Stroke Risk Score
|
Determines stroke risk in patients with atrial fibrillation
|
| Arrythmia/Stroke
|
Atrial Fibrillation Five Year Risk of Stroke (Framingham Heart Study)
|
Predicts 5-year risk of stroke in patients with atrial fibrillation
|
| Arrythmia/Stroke
|
Atrial Fibrillation Five Year Risk of Stroke or Death (Framingham Heart Study)
|
Predicts 5-year risk of stroke or death in patients with atrial fibrillation
|
| Alcoholism
|
CAGE Questions for Alcohol Use
|
Screens for excessive drinking and alcoholism
|
| Syncope
|
Canadian Syncope Risk Score
|
Predicts 30-day serious adverse events in patients presenting with syncope
|
| VTE
|
Caprini score
|
Stratifies risk of VTE in surgical patients
|
| MACE
|
Cardiac Risk Index for AAA Surgery (Lee)
|
Calculates the approximate risk of cardiac complication after AAA surgery
|
| MACE
|
Cardiac Risk Index for Abdominal Surgery (Lee)
|
Calculates the approximate risk of cardiac complication after abdominal surgery
|
| MACE
|
Cardiac Risk Index for Pre-Operative Risk, revised
|
Estimates risk of cardiac complications after noncardiac surgery
|
| MACE
|
Cardiovascular Risk Assessment (10-year, PROCAM Score, Munster Heart Study)
|
Predicts 10-year cardiovascular risk based on risk factors like history of MI, diabetes or high cholesterol
|
| Cardiac arrest
|
CART (Cardiac Arrest Risk Triage) Score
|
Predicts risk of in-hospital cardiac arrest
|
| Arrythmia/Stroke
|
CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk
|
Calculates stroke risk for patients with atrial fibrillation, possibly better than the CHADS₂ Score
|
| Arrythmia/Stroke
|
CHADS₂ Score for Atrial Fibrillation Stroke Risk
|
Estimates stroke risk in patients with atrial fibrillation
|
| Survival
|
Charlson Comorbidity Index (CCI)
|
Predicts 10-year survival in patients with multiple comorbidities
|
| Stroke
|
Cincinnati Prehospital Stroke Severity Scale (CP-SSS)
|
Predicts large vessel occlusion (LVO) and severe stroke in patients with stroke symptoms
|
| Coronary artery disease/Bleeding
|
CRUSADE Score for Post-MI Bleeding Risk
|
Stratifies bleeding risk after NSTEMI
|
| VTE
|
DASH Prediction Score for Recurrent VTE
|
Predicts likelihood of recurrence of first VTE
|
| Coronary artery disease
|
Dual Antiplatelet Therapy (DAPT) Score
|
Predicts which patients will benefit from prolonged DAPT after coronary stent placement
|
| Syncope
|
EGSYS (Evaluation of Guidelines in SYncope Study) Score for Syncope
|
Predicts likelihood that syncope is from cardiac cause
|
| VTE
|
Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis
|
Predicts need for VTE prophylaxis in admitted patients
|
| PE
|
Geneva score for PE, original
|
Determines the pre-test probability of PE based on a patient's risk factors and clinical findings
|
| PE
|
Geneva score for PE, revised
|
Objectifies risk of PE, like Wells’ score
|
| PE
|
Geneva score for PE, simplified
|
Determines the pre-test probability of PE based on a patient's risk factors and clinical findings
|
| Cardiac arrest/Survival
|
GO-FAR (Good Outcome Following Attempted Resuscitation) Score
|
Predicts survival to discharge with good outcome after in-hospital cardiac arrest
|
| Coronary artery disease
|
Grace Risk Score for All-Cause Mortality From Discharge to 6 Months
|
Assesses the risk of 6-month mortality among patients with acute coronary syndrome
|
| Coronary artery disease
|
Grace Risk Score for In-Hospital Mortality
|
Assesses the risk of in-hospital mortality among patients with acute coronary syndrome
|
| DVT
|
HAMILTON score
|
Assesses the pretest probability of DVT among ambulatory outpatients
|
| Bleeding
|
HAS-BLED Score for Major Bleeding Risk
|
Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care
|
| Coronary artery disease
|
HEART Pathway for Early Discharge in Acute Chest Pain
|
Identifies emergency department patients with acute chest pain for early discharge
|
| MACE
|
HEART Score for Major Cardiac Events
|
Predicts 6-week risk of major adverse cardiac event
|
| Arrythmia/Bleeding
|
HEMORR₂HAGES Score for Major Bleeding Risk
|
Quantifies risk of hemorrhage in elderly patients with AFib
|
| PE
|
Hestia Criteria for Outpatient Pulmonary Embolism Treatment
|
Identifies low-risk PE patients safe for outpatient treatment
|
| Bleeding
|
IMPROVE bleeding risk score
|
Estimates the probability of major or clinically important in-hospital bleeding from the time of hospital admission up to 14 days following admission
|
| VTE
|
IMPROVE VTE risk score
|
Estimates the probability of clinically evident acute venous thromboembolism from the time of hospital admission to discharge
|
| VTE
|
IMPROVEDD VTE risk score
|
Estimates the probability of venous thromboembolism from the time of hospital admission up to 77 days
|
| Infective endocarditis/Mortality
|
Infective Endocarditis (IE) Mortality Risk Score
|
Predicts mortality at 6 months in patients with infective endocarditis
|
| Coronary artery disease
|
Marburg Heart Score (MHS)
|
Rules out coronary artery disease in primary care patients with chest pain
|
| Nephropathy
|
Mehran Score for Post-PCI Contrast Nephropathy
|
Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI)
|
| Syncope/Mortality
|
OESIL Score for Syncope
|
Estimates 12-month all-cause mortality in patients presenting with syncope
|
| Heart failure
|
Ottawa Heart Failure Risk Scale (OHFRS)
|
Identifies ED patients with heart failure at high risk for serious adverse events
|
| VTE
|
Padua Prediction Score for Risk of VTE
|
Determines anticoagulation need in hospitalized patients by risk of VTE
|
| PE
|
PESI (Pulmonary Embolism Severity Index)
|
Predicts 30-day outcome of patients with pulmonary embolism using 11 clinical criteria
|
| PE
|
PESI (Pulmonary Embolism Severity Index), simplified
|
Predicts 30-day outcome of patients with PE, with fewer criteria than the original PESI
|
| PE/Bleeding
|
RIETE Score for Risk of Hemorrhage in Pulmonary Embolism Treatment
|
Determine the risk of major bleeding during anticoagulant therapy
|
| Stroke/Mortality
|
SOAR Score for Stroke, modified
|
Predicts short-term mortality in acute ischemic stroke
|
| Coronary artery disease
|
TIMI Risk Score for STEMI
|
Estimates mortality in patients with STEMI
|
| Coronary artery disease
|
TIMI Risk Score for UA/NSTEMI
|
Estimates mortality for patients with unstable angina and non-ST elevation MI
|
| DVT
|
Wells score for DVT, modified
|
Estimates the pre-test probability of DVT
|
| DVT
|
Wells score for DVT, original
|
Calculates Wells' Score for risk of DVT
|
| PE
|
Wells score for Pulmonary Embolism
|
Objectifies risk of pulmonary embolism
|
| PE
|
Wells score for pulmonary embolism, modified
|
Estimates the pre-test probability of PE
|
| PE
|
Wells score for pulmonary embolism, simplified
|
Estimates the pre-test probability of PE
|
| Anesthesia
|
Cardiac Anesthesia Risk Evaluation Score (CARE)
|
Predicts mortality and morbidity after cardiac surgery
|
|
|
Duke Activity Status Index (DASI)
|
Estimates functional capacity
|
| Ehlers-Danlos Syndrome
|
Ehlers-Danlos Syndrome IV (vascular type) Diagnostic Criteria
|
Diagnoses Ehlers-Danlos Syndrome IV (vascular type)
|
| Coronary artery disease
|
Emergency Department Assessment of Chest Pain Score (EDACS)
|
Identifies chest pain patients with low risk of major adverse cardiac event
|
| MACE
|
EuroSCORE for Cardiac Surgery Risk Assessment
|
Estimates the mortality among cardiac surgical adult patients
|
| MACE
|
Framingham 10 Year Coronary Risk Prediction by LDL (1998 paper)
|
Predicts 10-year risk of coronary heart disease
|
| MACE
|
Framingham 10 Year Coronary Risk Prediction by Total Cholesterol (1998 paper)
|
Predicts 10-year risk of coronary heart disease
|
| MACE
|
Framingham 10 Year Risk of General Cardiovascular Disease (2008 paper)
|
Predicts 10-year risk of heart disease
|
| Heart failure
|
Framingham Heart Failure Diagnostic Criteria
|
Diagnoses heart failure based on major and minor criteria
|
| Heart failure
|
GWTG-Heart Failure Risk Score
|
Predicts in-hospital all-cause heart failure mortality
|
| Takayasu arteritis
|
Indian Takayasu Clinical Activity Score (ITAS2010)
|
Differentiates between active and inactive disease in Takayasu arteritis (TA)
|
| Bleeding
|
Intracranial Bleeding Risk from Thrombolytic Therapy of MI
|
Estimates the risk of intracranial hemorrhage associated with thrombolytic therapy among MI patients
|
| Acute Rheumatic Fever
|
Jones Criteria for Acute Rheumatic Fever Diagnosis
|
Diagnoses acute rheumatic fever based on major and minor criteria
|
| Kawasaki Disease
|
Kawasaki Disease Diagnostic Criteria
|
Diagnoses Kawasaki Disease
|
| Heart failure
|
Killip Classification for Heart Failure
|
Quantifies severity of heart failure in ACS and predicts 30-day mortality
|
| Readmission/Mortality
|
LACE Index for Readmission
|
Predicts 30-day readmission or death in patients on medicine and surgery wards
|
| Heart failure/Mortality
|
MAGGIC Risk for Heart Failure
|
Estimates 1- and 3- year mortality in heart failure
|
| Metabolic syndrome
|
Metabolic Syndrome Criteria (AHA/NHLBI 2005)
|
Assists to diagnose and manage metabolic syndrome
|
| Metabolic syndrome
|
Metabolic Syndrome Criteria (ATP III)
|
Diagnoses of metabolic syndrome
|
| Dyspnea
|
mMRC (Modified Medical Research Council) Dyspnea Scale
|
Stratifies severity of dyspnea in respiratory diseases, particularly COPD
|
| Mortality
|
Modified Early Warning Score (MEWS) for Clinical Deterioration
|
Determines the degree of illness of a patient
|
| Chest pain
|
Newsom Score for Non-traumatic Chest Pain
|
Rules out need for chest x-ray in chest pain patients (non-traumatic)
|
| Pacer
|
Pacer Need After Heart Valve Surgery
|
Predicts the need for permanent pacing after cardiac valve surgery
|
|
|
Pediatric Early Warning Score (PEWS)
|
Identifies pediatric patients at risk for clinical deterioration
|
| PE
|
PERC Rule for Pulmonary Embolism
|
Rules out PE if no criteria are present and pre-test probability is ≤15%
|
| Operation
|
PTCA Mortality Prediction
|
Predicts the risk of major in-hospital complications following percutaneous coronary interventions
|
| Pulmonary arterial hypertension
|
REVEAL Registry Risk Score for Pulmonary Arterial Hypertension (PAH)
|
Predicts survival in patients with pulmonary arterial hypertension
|
| Stroke
|
Risk of Paradoxical Embolism (RoPE) Score
|
Identifies stroke-related PFO in patients with cryptogenic stroke
|
| Imaging
|
Romhilt-Estes Criteria for Left Ventricular Hypertrophy
|
Electrocardiographic criteria for the diagnosis of left ventricular hypertrophy
|
| Syncope
|
San Francisco Syncope Rule
|
Defines high-risk criteria for patients with syncope
|
| Coronary artery disease
|
Sgarbossa's Criteria for MI in Left Bundle Branch Block
|
Criteria to diagnose acute MI in patients with prior LBBB
|
| Imaging
|
Stress Test Outcome Risk Factors
|
Predicts outcome in a community-based population undergoing stress testing
|
| Stroke
|
tPA Contraindications for Ischemic Stroke
|
Provides inclusion/exclusion criteria when deciding to use tPA on a patient with acute ischemic stroke
|
| Coronary artery disease
|
Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid
|
Rules out acute coronary syndrome
|
| Coronary artery disease
|
Unstable Angina and Tirofiban Benefit Prediction
|
Predicts adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris
|
| Coronary artery disease
|
Unstable Angina Risk Stratification (Piombo)
|
Predicts stratify risk in unstable angina
|
| Coronary artery disease
|
Unstable Angina Risk Stratification (Solomon)
|
Identifies patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy
|
